Confined or spread disease-Confined only to the breast Posts on Medivizor

Comparing the effectiveness and safety of trastuzumab emtansine plus pertuzumab versus taxane plus trastuzumab plus pertuzumab in patients with high-risk HER2+ early breast cancer.

Posted by Medivizor on Apr 14, 2022 in Breast cancer | 0 comments

In a nutshell This study compared the effectiveness and safety of trastuzumab emtansine (T-DM1; Kadcyla) plus pertuzumab (Perjeta) versus taxanes plus trastuzumab (Herceptin) plus pertuzumab (THP) in patients with high-risk HER2-positive (+) early breast cancer (BC) after previous treatment with anthracycline-based chemotherapy. The data showed that...

Evaluating the long-term outcome of using gonadotropin-releasing hormone agonist during chemotherapy to preserve ovarian function in premenopausal patients with early-stage breast cancer.

Posted by Medivizor on Jan 30, 2022 in Breast cancer | 0 comments

In a nutshell This study evaluated the long-term outcomes of using gonadotropin-releasing hormone (GnRH) agonist during chemotherapy to preserve ovarian function in premenopausal patients with early-stage breast cancer (BC). The data showed that GnRH agonist use during chemotherapy was safe and effective to preserve ovarian function in these...

Comparing platinum-based chemotherapy and immunotherapy for the treatment of patients with early-stage triple negative breast cancer.

Posted by Medivizor on Sep 12, 2021 in Breast cancer | 0 comments

In a nutshell This study compared the effectiveness and safety outcomes of platinum-based chemotherapy and immune checkpoint inhibitors (ICIs) for the treatment of patients with early-stage triple-negative breast cancer (TNBC). The data showed that ICI plus chemotherapy was associated with good outcomes with reduced side effects compared with...

Evaluating the benefits of denosumab on bone health in women with early-stage breast cancer.

Posted by Medivizor on Sep 5, 2021 in Breast cancer | 0 comments

In a nutshell This study evaluated the benefits of denosumab (Xgeva) on the bone health of women with early-stage breast cancer (BC). The data showed that denosumab improved bone-related outcomes in women with high-risk early-stage BC Some background BC is one of the most common forms of cancer in women. Early-stage BC is used to describe BC that is...

Does radiotherapy with electrons boost during surgery reduce the risk of breast cancer recurrence?

Posted by Medivizor on May 16, 2021 in Breast cancer | 0 comments

In a nutshell The authors investigated whether intra-operative electron radiotherapy (IOERT) boost reduces breast cancer recurrence compared to standard radiotherapy. They found that IOERT slightly reduced cancer recurrence compared to standard external beam radiotherapy (EBRT). Some background Breast cancer is the most commonly diagnosed...

Comparing 2 radiation treatments for elderly women with low-risk breast cancer

Posted by Medivizor on May 15, 2021 in Breast cancer | 0 comments

In a nutshell This article compared the outcomes of older patients with low-risk breast cancer treated with accelerated partial breast irradiation (APBI) or ultra-APBI. The authors found that both treatment methods resulted in similar outcomes and side effects in these patients. Some background Breast cancer is the most commonly diagnosed...

Can intraoperative radiotherapy be used to treat early-stage breast cancer?

Posted by Medivizor on Mar 6, 2021 in Breast cancer | 0 comments

In a nutshell This article looked at 5-year outcomes of intraoperative radiation therapy (IORT) for breast cancer (BC). The authors found that IORT may have a higher rate of cancer return compared to whole-breast radiation therapy (WBRT). Some background BC is one of the most common forms of cancer found in women. Standard care for BC is usually a...

Looking for patients with breast reconstructions following breast surgery to trial a short radiation therapy

Posted by Medivizor on Jan 28, 2021 in Breast cancer | 0 comments

In a nutshell This trial is looking to examine the use of radiation on a shorter schedule of 5 days in a row is a safe and effective way to prevent breast cancer (BC) from coming back in people who have had a mastectomy (surgical removal of the breast). The main outcomes that are to be measured are local and regional disease recurrence. This trial is to...

Evaluating radiation therapy after breast removal surgery for node-positive triple-negative breast cancer.

Posted by Medivizor on Dec 28, 2020 in Breast cancer | 0 comments

In a nutshell This study was carried out to assess the use of radiotherapy (RT) after mastectomy (surgical removal of the breast) for triple-negative breast cancer (TNBC) that has spread to the lymph nodes. The authors found that RT after surgery was associated with improved survival in patients with larger tumors. Some background Triple-negative...

Comparing long-term outcomes of whole or partial breast irradiation after breast-conserving surgery

Posted by Medivizor on Dec 13, 2020 in Breast cancer | 0 comments

In a nutshell This study compared whole breast irradiation (WBI) to partial breast irradiation (PBI) following breast-conserving surgery (BCS) in patients with low-risk breast cancer. The study showed similar survival between the 2 treatments, while PBI gave better cosmetic results. Some background Patients with low-risk breast...

Comparing breast-conserving surgery and breast-removal surgery after chemotherapy in patients with breast cancer

Posted by Medivizor on Nov 5, 2020 in Breast cancer | 0 comments

In a nutshell This study compared the effectiveness of breast-conserving surgery (BCS) to mastectomy (breast-removal surgery) after chemotherapy in patients with breast cancer. The authors found that BCS does not result in a lower survival in these patients. Some background BC is one of the most common forms of cancer in women. Standard care...

Comparing hormone therapy and radiation after breast conserving surgery for older patients with early-stage breast cancer

Posted by Medivizor on Oct 4, 2020 in Breast cancer | 0 comments

In a nutshell This study compared the survival rates for older patients with early-stage breast cancer (BC) receiving hormone therapy (HT), radiation (RT), both or none after breast-conserving surgery (BCS). The data showed that RT and HT in combination and RT alone may lead to higher survival expectancy than HT alone. Some...

Confined or spread disease-Confined only to the breast Posts on Medivizor

Comparing the effectiveness and safety of trastuzumab emtansine plus pertuzumab versus taxane plus trastuzumab plus pertuzumab in patients with high-risk HER2+ early breast cancer.

Evaluating the long-term outcome of using gonadotropin-releasing hormone agonist during chemotherapy to preserve ovarian function in premenopausal patients with early-stage breast cancer.

Comparing platinum-based chemotherapy and immunotherapy for the treatment of patients with early-stage triple negative breast cancer.

Evaluating the benefits of denosumab on bone health in women with early-stage breast cancer.

Does radiotherapy with electrons boost during surgery reduce the risk of breast cancer recurrence?

Comparing 2 radiation treatments for elderly women with low-risk breast cancer

Can intraoperative radiotherapy be used to treat early-stage breast cancer?

Looking for patients with breast reconstructions following breast surgery to trial a short radiation therapy

Evaluating radiation therapy after breast removal surgery for node-positive triple-negative breast cancer.

Comparing long-term outcomes of whole or partial breast irradiation after breast-conserving surgery

Comparing breast-conserving surgery and breast-removal surgery after chemotherapy in patients with breast cancer

Comparing hormone therapy and radiation after breast conserving surgery for older patients with early-stage breast cancer

Categories

Recent Posts

Archives

Confined or spread disease-Confined only to the breast Posts on Medivizor

Categories

Recent Posts

Archives

Thanks for your interest in Medivizor

Invalid email